Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.

» Details

Guru Trades

Q3 2015

VEU Guru Trades in Q3 2015

First Eagle Investment 73,800 sh (unchged)
» More
Q4 2015

VEU Guru Trades in Q4 2015

First Eagle Investment 9,800 sh (-86.72%)
» More
Q1 2016

VEU Guru Trades in Q1 2016

First Eagle Investment 9,800 sh (unchged)
» More
Q2 2016

VEU Guru Trades in Q2 2016

First Eagle Investment Sold Out
» More

Ratios

vs
industry
vs
history
PE Ratio 18.22
VEU's PE Ratio is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. VEU: 18.22 )
Ranked among companies with meaningful PE Ratio only.
VEU' s PE Ratio Range Over the Past 10 Years
Min: 0  Med: 0 Max: 18.3
Current: 18.22
0
18.3
PE Ratio without NRI 18.22
VEU's PE Ratio without NRI is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. VEU: 18.22 )
Ranked among companies with meaningful PE Ratio without NRI only.
VEU' s PE Ratio without NRI Range Over the Past 10 Years
Min: 0  Med: 0 Max: 18.3
Current: 18.22
0
18.3
PB Ratio 1.74
VEU's PB Ratio is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. VEU: 1.74 )
Ranked among companies with meaningful PB Ratio only.
VEU' s PB Ratio Range Over the Past 10 Years
Min: 0  Med: 0 Max: 1.74
Current: 1.74
0
1.74

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 2.68
VEU's Dividend Yield % is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. VEU: 2.68 )
Ranked among companies with meaningful Dividend Yield % only.
VEU' s Dividend Yield % Range Over the Past 10 Years
Min: 0  Med: 0 Max: 2.71
Current: 2.68
0
2.71
5-Year Yield-on-Cost % 2.68
VEU's 5-Year Yield-on-Cost % is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. VEU: 2.68 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
VEU' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0  Med: 0 Max: 2.71
Current: 2.68
0
2.71

More Statistics

Short Percentage of Float0.00%
52-Week Range $40.43 - 49.01
Shares Outstanding (Mil)99,999,999.99
» More Articles for VEU

Headlines

Articles On GuruFocus.com
What A Wonderful Market (And Where This Leads Us) Jul 07 2014 

More From Other Websites
French Election: Is the Protectionist Agenda Still in Play? Apr 27 2017
Why AstraZeneca Could See Lower Revenues in 1Q17 Apr 26 2017
The Syria Conundrum: Is Turkey with the US or Russia? Apr 21 2017
China’s Manufacturing Sector and Rising Industrial Production in 2017 Apr 19 2017
Trump’s Role in the Market’s Current Guessing Game Apr 19 2017
How the Economy and Markets Could React to Tax Reforms Apr 05 2017
Zacks Podcast Highlights: Are U.S. Investors Focused on the Wrong Markets Right Now? Apr 04 2017
Investigational Breast Cancer Drug Could Boost Novartis’s Position Apr 03 2017
Will Novartis’s Alcon Business See Growth in 2017? Apr 03 2017
Novartis Has Developed a Robust Innovation Strategy Mar 31 2017
An Aggressive Retirement Saver Portfolio for ETF Investors Mar 31 2017
Novartis’s Cosentyx Managed to Achieve Blockbuster Status in 2016 Mar 29 2017
With low yields abroad, investors hunt for international dividend funds Mar 28 2017
Japan’s Manufacturing PMI Is Weakening: What It Means for the Economy Mar 28 2017
Exploring Novartis’s 2016 Revenue Mar 24 2017
Will China’s Improved Industrial Production Impact Manufacturing? Mar 24 2017
AstraZeneca Expects Fall in Net Profit Margins in 2017 Feb 28 2017
Japan’s Manufacturing PMI Is Improving Feb 27 2017
Teva Is Expected to Witness a Modest Revenue Rise in 2017 Feb 23 2017
This Guy Built A Superdiversified Portfolio With 10 ETFs Feb 21 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK